Cambridge Innovation Capital (CIC) is a venture capital firm that invests in deep tech and life sciences businesses, primarily focusing on companies with an affiliation to the Cambridge ecosystem and spinouts from the University of Cambridge. Their strategy involves providing Series A and growth-stage funding, along with expert guidance, to help these promising ventures become world-leading companies.
Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $34.5M (across 16 rounds with reported amounts).
Portfolio
16
Fund Size
$600M
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| TTrent AI | Seed | $13M | Apr 2026 |
 Immutrin | Series A | $87M | Mar 2026 |
 BeyondMath | Seed | $18.5M | Feb 2026 |
 Cambridge GaN Devices | Series C | $30.5M | Feb 2025 |
 Salience Labs | Series A | $30M | Feb 2025 |
 Forefront RF | Series A | $20M | Nov 2024 |
 Nuclera | Series C | $75M | Oct 2024 |
 Riverlane | Series C | $75M | Aug 2024 |
 Seldon | Series B | $20M | Mar 2023 |
| Riverlane | Seed | $3.7M | Jun 2019 |
 Cytora | Series B | $32.5M | Apr 2019 |
| SSwim.ai | Series B | $10M | Jul 2018 |
| UUndo | Series B | $14M | Jul 2018 |
 Carrick Therapeutics Ltd | Series A | $95M | Oct 2016 |
| Riverlane | Series A | $20M | — |
| AAudioTelligence | Series A | $8.5M | — |
Top Co-Investors
Amadeus Capital Partners4 shared
Parkwalk Advisors3 shared
Cambridge Enterprise3 shared
British Patient Capital2 shared
BGF2 shared
Foresight Ventures2 shared
Octopus Ventures2 shared
AlbionVC1 shared
Braavos1 shared
Oxford Science Enterprises1 shared
Silicon Catalyst Ventures1 shared
IQ Capital1 shared
UP.Partners1 shared
Insight Partners1 shared
InMotion Ventures1 shared
Global Brain Corporation1 shared
Draper Esprit1 shared
University of Cambridge1 shared
EQT Ventures1 shared
ETF partners1 shared
Last updated: 16 April 2026